Comparative effectiveness of umeclidinium/ vilanterol versus indacaterol/glycopyrronium on acute exacerbations in patients with chronic obstructive pulmonary disease in England

05.01 - Airway pharmacology and treatment(2023)

引用 0|浏览5
暂无评分
摘要
Background Real-world evidence comparing long-acting muscarinic antagonist/long-acting β2-agonist dual therapies on acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is limited.
更多
查看译文
关键词
chronic obstructive pulmonary disease,indacaterol/glycopyrronium,indacaterol/glycopyrronium,acute exacerbations,umeclidinium/vilanterol
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要